Results 141 to 150 of about 18,010 (199)

Real-world effectiveness and safety of meropenem–vaborbactam in the treatment of carbapenem-resistant enterobacterales (CRE) infections: a systematic review and meta-analysis [PDF]

Dongcai Jin, Danyang Hu, Yuhong Jin
openalex   +1 more source

Pathogen-Specific Clinical Trials: A New Paradigm in Clinical Trials for Multidrug-Resistant Organisms

Infectious Diseases and Therapy, 2018
Sarah C. J. Jorgensen, Michael J. Rybak
doaj   +1 more source

A molecular analysis of meropenem-vaborbactam non-susceptible KPC-producing Klebsiella pneumoniae. [PDF]

Antimicrob Agents Chemother
Yasmin M, Marshall SH, Chen L, Rhoads DD, Jacobs MR, Rojas LJ, Perez F, Hujer AM, Hujer KM, van Duin D, Fowler V, Chambers HF, Kreiswirth BN, Bonomo RA, Antibacterial Resistance Leadership Group.   +14 more
europepmc   +1 more source

Biliary pharmacokinetic/pharmacodynamic analysis of continuous infusion meropenem/vaborbactam in a case series of orthotopic liver transplant recipients. [PDF]

J Antimicrob Chemother
Gatti M, Rinaldi M, Laici C, Ambretti S, Siniscalchi A, Viale P, Pea F.   +6 more
europepmc   +1 more source

Distributions of plasmidic genes encoding extended-spectrum and AmpC β-lactamases, and susceptibilities of global non-carbapenemase-producing meropenem-resistant Enterobacterales to ceftazidime-avibactam, meropenem-vaborbactam, and aztreonam-avibactam, 2017–2022 [PDF]

Shio‐Shin Jean, Hou-Tai Chang, Chaolin Huang, I-Min Liu, Po-Chuen Hsieh, Po‐Ren Hsueh   +5 more
openalex   +1 more source

Effect of Ceftaroline, Ceftazidime/Avibactam, Ceftolozane/Tazobactam, and Meropenem/Vaborbactam on Establishment of Colonization by Vancomycin-Resistant Enterococci and Klebsiella pneumoniae in Mice. [PDF]

Pathog Immun
Hausman BS, Memic S, Cadnum JL, Zink EG, Wilson BM, Donskey CJ.   +5 more
europepmc   +1 more source

Evaluation of imipenem-relebactam, meropenem-vaborbactam, aztreonam-avibactam and cefepime-zidebactam activities on a wide collection of French clinical Enterobacterales isolates

Camille Petillon, Mauli Ulutuipalelei, Racha Beyrouthy, S. Proust, Nejla Aissa, Laurent Bret, Nathalie Brieu, Anne Carricajo, Vincent Cattoir, Olivier Dauwalder, Nicolas Degand, Laurent Dortet, Florence Doucet‐Populaire, Véronique Dubois, Antoine Grillon, François Guérin, Philippe Lanotte, Nadine Lemaître, David Leyssene, Catherine Neuwirth, Isabelle Patry, Marie-Cécile Ploy, Isabelle Podglajen, C. Recule, Karama Rouis, Onerba Réseau, J. Robert, Richard Bonnet, Frédéric Robin   +28 more
openalex   +2 more sources

In vitro activity and genomic characterization of KPC-producing Klebsiella pneumoniae clinical blood culture isolates resistant to ceftazidime/avibactam, meropenem/vaborbactam, imipenem/relebactam: an Italian nationwide multicentre observational study (2022–23) [PDF]

Gabriele Bianco, Matteo Boattini, Laura Isabella Lupo, Simone Ambretti, Rita Greco, Linda Degl’Innocenti, Sofia Chiatamone Ranieri, Teresa Fasciana, Annarita Mazzariol, Davide Gibellini, Guido Antonelli, Federica Sacco, Angela Quirino, Claudio Farina, Bianca Paglietti, Sara Comini, Maura Fiamma, Francesco Broccolo, Rossana Cavallo, Cristina Costa, Paolo Gaibani   +20 more
openalex   +1 more source

RP-HPLC Method Development and Validation for the simultaneous estimation of Meropenem and Vaborbactam in its pure and Dosage form

Tahseen Sultana, Vara Saritha, Sujatha Dr.S, G Navyasri   +3 more
openalex   +2 more sources